Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers

Completed · Phase 1 · Has a placebo group

Conditions studied: Alcohol Use Disorder

In brief

This is a double-blind, randomized, placebo-controlled, crossover design trial tested the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this study was to determine whether lacosamide, a novel anticonvulsant that is FDA-approved for treating partial seizures, has effects on alcohol craving and consumption.

Key facts

Study ID

NCT03271528

Run by

Boston Medical Center

People needed

66

Starts

2018-04-15

Expected to finish

2020-08-31

Last updated by the study team

2021-06-03

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Boston University Psychiatry Research Center, Clinical Studies Unit — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.